You are here

Tamara L. Trienski, PharmD

Tamara L. Trienski, PharmD

Clinical Pharmacy Specialist, Infectious Diseases

Education and Training

BS Pharmacy, Duquesne University, Pittsburgh PA (1987)

PharmD, Duquesne University, Pittsburgh PA (1999)

Antimicrobial Stewardship – Basic Certificate, MAD-ID (2010)

Antimicrobial Stewardship – Advanced Certificate, MAD-ID (2012)

Professional Memberships

American College of Clinical Pharmacy

American Society of Health-System Pharmacists

Infectious Disease Society of America

Society of Infectious Diseases Pharmacists

Clinical and Research Interests

Dr. Trienski’s clinical and research interests include outcomes related to antimicrobial stewardship, and utilization of rapid diagnostics and biomarkers to aid in optimization of antimicrobial therapy .

Selected Publications

  1. Walsh TL, DiSilvio BE, Hammer C, Beg M, Vishwanathan S, Speredelozzi D, Moffa MA, Hu K, Abdulmassih R, Makadia JT, Sandhu R, Naddour M, Chan-Tompkins NH, Trienski TL, Watson C, Obringer TJ, Kuzyck J, Bremmer DN. Impact of procalcitonin guidance with an educational program on management of adults hospitalized with pneumonia. The American Journal of Medicine [In press]
  2. Walsh TL, Bremmer DN, Moffa MA, Chan-Tompkins NH, Murillo MA, Chan L, Burkitt MJ, Konopka CI, Watson C, Trienski TL. Effect of antimicrobial stewardship program guidance on the management of uncomplicated skin and soft tissue infections in hospitalized adults. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2017;1(1):91-99
  3. Walsh TL, DiSilvio BE, Speredelozzi D, Hammer CD, Hu K, Abdulmassih R, Makadia JT, Sandhu R, Naddour M, Vishwanathan S, Chan-Tompkins NH, Trienski TL, Moffa MA, Bremmer DN. Evaluation of management of uncomplicated community-acquired pneumonia: a retrospective assessment. Infectious Diseases in Clinical Practice 2017;25(2):71-75
  4. Pasquale TR, Tan MJ, Trienski TL, File Jr. TM. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.  J Chemother. 2015 Feb 19 ;27(1):29-34.  Epub 2013  Dec 19.
  5. Trienski TL, File TM.  Implementation of a Procalcitonin Assay Requires Appropriate Stewardship to Result in Improved Antimicrobial Use.  Infectious Diseases in Clinical Practice.  2015 January, 23(1):1-2.
  6. Pasquale TR, Trienski TL, Olexia DE, Myers JP, Tan JL, Leung AK, Poblete JE, File Jr. TM.  Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections.  Am J Health Syst Pharm.  2014 Jul 1:71(13):1136-9.
  7. Bishop BM, Bon JJ, Trienski TL, Pasquale TR, Martin BR, File Jr. TM.  Effect of Introducing Procalcitonin on Antimicrobial Therapy Duration in Patients With Sepsis and/or Pneumonia in the Intensive Care Unit.  Ann Pharmacother.  2014 May;48(5):577-83.
  8. Trienski TL, Barrett HL, Pasquale TR, DiPersio JR, File Jr. TM.  Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program.  Am J Health Syst Pharm.  2013 Nov 1;70(21):1908-12.
  9. Dhiman N, Trienski TL, DiPersio LP, DiPersio JR.  Evaluation of the BinawNOW Staphylococcus aureus test for rapid identification of Gram-positive cocci from VersaTREK blood culture bottles.  J Clin Microbiol.  2013 Sep;51(9):2939-42.
  10. Trienski TL, Pasquale TR.  The Changing Face of Complicated Skin and Skin Structure Infections:  An Opportunity for Antimicrobial Stewardship.   Infectious Diseases in Clinical Practice.  2013 May, 21(3): 147-148.

Contact Information

Allegheny General Hospital, Department of Pharmacy
320 East North Avenue
Pittsburgh, PA 15212